Big Names Weigh In

While personal genomics companies say their tests have predictive value and will be helpful in health and wellness, The Economist asks what David Altshuler, Craig Venter, Russ Altman, George Church, and others think. Altshuler says that companies encourage people to read too deeply into their genomes -- he refused to have his sequenced -- and that he's worried about a backlash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Church Opens Up

Flawed Analysis

Just Look Within

Just a Hairy Elephant

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."